Published in J Am Soc Nephrol on September 01, 2011
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile. Clin Kidney J (2014) 0.85
A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo. Oxid Med Cell Longev (2014) 0.83
The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann N Y Acad Sci (2016) 0.83
Anticoagulants and acute kidney injury: clinical and pathology considerations. Kidney Res Clin Pract (2014) 0.82
Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol (2013) 0.81
Brodifacoum induces early hemoglobinuria and late hematuria in rats: novel rapid biomarkers of poisoning. Am J Nephrol (2015) 0.80
Warfarin related acute kidney injury: A case report. Indian J Nephrol (2017) 0.75
Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases. Clin Kidney J (2017) 0.75
The Severity of Intracranial Hemorrhages Measured by Free Hemoglobin in the Brain Depends on the Anticoagulant Class: Experimental Data. Stroke Res Treat (2017) 0.75
Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity. Int Urol Nephrol (2017) 0.75
Recommendations for the use of new oral anticoagulants (NOACs) after TIA or stroke caused by atrial fibrillation (AF), after a consensus conference among Italian neurologists (the Venice group). Neurol Sci (2013) 0.75
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int (2011) 4.51
Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis (2009) 2.21
Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int (2006) 2.06
Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol (2004) 1.88
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract (2010) 1.62
Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol (1994) 1.50
Gas6, warfarin, and kidney diseases. Clin Exp Nephrol (2004) 1.40
Role of growth hormone in the development of experimental renal scarring. Kidney Int (1991) 1.38
Mechanism of inhibitory effect of warfarin on mesangial cell proliferation. J Am Soc Nephrol (1999) 1.09
Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction. Am J Physiol (1993) 0.89
Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats. Eur J Pharm Sci (2006) 0.84
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int (2011) 4.51
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med (2016) 2.83
Management of glomerular proteinuria: a commentary. J Am Soc Nephrol (2003) 2.59
Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med (2007) 2.50
Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol (2004) 2.49
Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol (2009) 2.45
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A (2002) 2.31
Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis (2009) 2.21
Myocardial bridging of coronary arteries: A risk factor for myocardial fibrosis? Int J Cardiol (2007) 2.01
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol (2005) 1.90
Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling. Dev Biol (2005) 1.90
Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension (2002) 1.83
A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int (2011) 1.77
Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur J Immunol (2005) 1.74
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) (2011) 1.70
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol (2007) 1.63
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol (2014) 1.62
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract (2010) 1.62
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success. Am J Nephrol (2012) 1.57
Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am J Pathol (2006) 1.57
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther (2009) 1.54
Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int (2008) 1.51
Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol (2005) 1.50
A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma. Ann Surg Oncol (2007) 1.49
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int (2005) 1.40
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum (2012) 1.32
An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy. Am J Kidney Dis (2004) 1.31
Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol (2004) 1.29
Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol (2006) 1.26
A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet (2007) 1.25
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice? Clin J Am Soc Nephrol (2012) 1.25
A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int (2009) 1.24
Proliferative glomerulonephritis with monoclonal IgG deposits recurs or may develop de novo in kidney allografts. Am J Kidney Dis (2011) 1.20
Optimizing ACE-inhibitor therapy for chronic kidney disease. N Engl J Med (2006) 1.18
Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis (2006) 1.18
Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis (2007) 1.18
Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol (2002) 1.17
Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int (2002) 1.15
The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun (2004) 1.15
A functional annotation of subproteomes in human plasma. Proteomics (2005) 1.15
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2007) 1.13
Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis (2006) 1.12
Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res (2002) 1.11
IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol (2013) 1.10
Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol (2006) 1.10
Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol (2015) 1.09
Infection-related glomerulonephritis: understanding mechanisms. Semin Nephrol (2011) 1.07
Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO. J Immunol (2008) 1.07
Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani. J Immunol (2006) 1.06
Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol (2004) 1.05
Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum (2005) 1.05
Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation (2009) 1.05
Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii. FASEB J (2008) 1.04
Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia. Am J Physiol Renal Physiol (2004) 1.02
Primary malignant myopericytoma of the left atrium--a tumor of aggressive biological behavior: report of the first case and review of literature. Appl Immunohistochem Mol Morphol (2015) 1.02
Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis (2008) 1.02
The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. Cytokine (2002) 1.01
My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.00